Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that it enclosed extracts of the consolidated unaudited financial results of the Company for the quarter and half year ended on September 30, 2024 as published in ‘Financial Express’ and ‘Jansatta’ on November 6, 2024.
The above information is a part of company’s filings submitted to BSE.